drugset / Trial / NCT01118429

Use of Oxybutynin to Treat Axillary Hyperhidrosis

NCT01118429

Completed 100 enrolled Grupo de Cirurgia Vascular
NaSingle-groupOpen-labelTreatment

Summary

The objective of this study was to evaluate the effectiveness and patient satisfaction with the use of oxybutynin at low doses for treating axillary hyperhidrosis in a large series of patients.

Timeline

Start
2007-01
Primary completion
2009-06
Completion
2009-06

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Oxybutynin Small molecule 5 mg